Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C174298-100 100 µl (1 mg/ml) $450 
EGR2 Antibody - IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-EGR2 mouse monoclonal antibody.
EGR2 Antibody - Anti-EGR2 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY EGR2.
EGR2 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY EGR2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-EGR2.
EGR2 Antibody - IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-EGR2 mouse monoclonal antibody.
EGR2 Antibody - Anti-EGR2 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY EGR2.
EGR2 Antibody - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY EGR2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-EGR2.
1 of 3
2 of 3
3 of 3

Monoclonal Mouse anti‑Human EGR2 Antibody (clone OTI1B12, IHC, IF, WB) LS‑C174298

Monoclonal Mouse anti‑Human EGR2 Antibody (clone OTI1B12, IHC, IF, WB) LS‑C174298

Antibody:
EGR2 Mouse anti-Human Monoclonal (OTI1B12) Antibody
Application:
IHC, IHC-P, IF, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:
Price
Catalog Number
$450
LS-C174298-100
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
EGR2 Mouse anti-Human Monoclonal (OTI1B12) Antibody
Application:
IHC, IHC-P, IF, WB
Reactivity:
Human
Format:
Unconjugated, Unmodified
Other formats:

Specifications

Description
EGR2 antibody LS-C174298 is an unconjugated mouse monoclonal antibody to human EGR2. Validated for IF, IHC and WB.
Target
Human EGR2
Synonyms
EGR2 | CMT1D | CMT4E | Early growth response 2 | E3 SUMO-protein ligase EGR2 | EGR-2 | KROX20 | Krox-20 | AT591 | Zinc finger protein Krox-20
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG1 Monoclonal
Clone
OTI1B12
Conjugations
Unconjugated
Purification
Protein A/G purified
Modifications
Unmodified. Also available Carrier-free.
Immunogen
Human recombinant protein fragment corresponding to amino acids 156-476 of human EGR2(NP_000390) produced in E. coli.
Specificity
Human EGR2
Applications
  • IHC
  • IHC - Paraffin (1:150)
  • Immunofluorescence (1:100)
  • Western blot (1:500)
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
Presentation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Storage
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About EGR2
P11161 NM_000399 NP_000390.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 12/26/2024